BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 33868994)

  • 1. Half-Brain Delineation for Prediction of Radiation-Induced Temporal Lobe Injury in Nasopharyngeal Carcinoma Receiving Intensity-Modulated Radiotherapy.
    Du QH; Gan YX; Wang RS; Liu WQ; Li J; Liang FF; Li XD; Zhu HJ; Ou X; Zhong QL; Luo DJ; Zhu ZP; Zhu SY
    Front Oncol; 2021; 11():599942. PubMed ID: 33868994
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic variables for temporal lobe injury after intensity modulated-radiotherapy of nasopharyngeal carcinoma.
    Feng M; Huang Y; Fan X; Xu P; Lang J; Wang D
    Cancer Med; 2018 Mar; 7(3):557-564. PubMed ID: 29473319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and dosimetric characteristics of temporal lobe injury following intensity modulated radiotherapy of nasopharyngeal carcinoma.
    Su SF; Huang Y; Xiao WW; Huang SM; Han F; Xie CM; Lu TX
    Radiother Oncol; 2012 Sep; 104(3):312-6. PubMed ID: 22857858
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Temporal lobe injury patterns following intensity modulated radiotherapy in a large cohort of nasopharyngeal carcinoma patients.
    Lu L; Sheng Y; Zhang G; Li Y; OuYang PY; Ge Y; Xie T; Chang H; Deng X; Wu JQ
    Oral Oncol; 2018 Oct; 85():8-14. PubMed ID: 30220323
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Normal tissue complication probability (NTCP) models for predicting temporal lobe injury after intensity-modulated radiotherapy in nasopharyngeal carcinoma: A large registry-based retrospective study from China.
    Wen DW; Lin L; Mao YP; Chen CY; Chen FP; Wu CF; Huang XD; Li ZX; Xu SS; Kou J; Yang XL; Ma J; Sun Y; Zhou GQ
    Radiother Oncol; 2021 Apr; 157():99-105. PubMed ID: 33484752
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of dosimetric factors on occurrence and volume of temporal lobe necrosis following intensity modulated radiation therapy for nasopharyngeal carcinoma: a case-control study.
    Zhou X; Ou X; Xu T; Wang X; Shen C; Ding J; Hu C
    Int J Radiat Oncol Biol Phys; 2014 Oct; 90(2):261-9. PubMed ID: 25066214
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiation-induced temporal lobe injury after intensity modulated radiotherapy in nasopharyngeal carcinoma patients: a dose-volume-outcome analysis.
    Sun Y; Zhou GQ; Qi ZY; Zhang L; Huang SM; Liu LZ; Li L; Lin AH; Ma J
    BMC Cancer; 2013 Aug; 13():397. PubMed ID: 23978128
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dosimetric analysis of radiation-induced brainstem necrosis for nasopharyngeal carcinoma treated with IMRT.
    Fan X; Huang Y; Xu P; Min Y; Li J; Feng M; Xu G; Lang J
    BMC Cancer; 2022 Feb; 22(1):178. PubMed ID: 35177030
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Normal tissue complication probability model of temporal lobe injury following re-irradiation of IMRT for local recurrent nasopharyngeal carcinoma.
    Guan X; Peng J; Sun J; Xing X; Hu C
    Front Oncol; 2024; 14():1394111. PubMed ID: 38873258
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dosimetric predictors of temporal lobe injury after intensity-modulated radiotherapy for T4 nasopharyngeal carcinoma: a competing risk study.
    Huang J; Kong FF; Oei RW; Zhai RP; Hu CS; Ying HM
    Radiat Oncol; 2019 Feb; 14(1):31. PubMed ID: 30736809
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential Defects and Improvements of Equivalent Uniform Dose Prediction Model Based on the Analysis of Radiation-Induced Brain Injury.
    Du QH; Li J; Gan YX; Zhu HJ; Yue HY; Li XD; Ou X; Zhong QL; Luo DJ; Xie YT; Liang QF; Wang RS; Liu WQ
    Front Oncol; 2021; 11():743941. PubMed ID: 35087743
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Normal Tissue Complication Probability Model for Radiation-induced Temporal Lobe Injury after Intensity-modulated Radiation Therapy for Nasopharyngeal Carcinoma.
    Zeng L; Huang SM; Tian YM; Sun XM; Han F; Lu TX; Deng XW
    Radiology; 2015 Jul; 276(1):243-9. PubMed ID: 25658039
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LASSO-based NTCP model for radiation-induced temporal lobe injury developing after intensity-modulated radiotherapy of nasopharyngeal carcinoma.
    Kong C; Zhu XZ; Lee TF; Feng PB; Xu JH; Qian PD; Zhang LF; He X; Huang SF; Zhang YQ
    Sci Rep; 2016 May; 6():26378. PubMed ID: 27210263
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A retrospective dosimetry study of intensity-modulated radiotherapy for nasopharyngeal carcinoma: radiation-induced brainstem injury and dose-volume analysis.
    Yao CY; Zhou GR; Wang LJ; Xu JH; Ye JJ; Zhang LF; He X; Chen ZZ; Huang SF
    Radiat Oncol; 2018 Oct; 13(1):194. PubMed ID: 30285884
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of dosimetric factors associated with temporal lobe necrosis (TLN) in patients with nasopharyngeal carcinoma (NPC) after intensity modulated radiotherapy.
    Su SF; Huang SM; Han F; Huang Y; Chen CY; Xiao WW; Sun XM; Lu TX
    Radiat Oncol; 2013 Jan; 8():17. PubMed ID: 23336282
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dosimetric comparison between 2-dimensional radiation therapy and intensity modulated radiation therapy in treatment of advanced T-stage nasopharyngeal carcinoma: to treat less or more in the planning organ-at-risk volume of the brainstem and spinal cord.
    Chau RM; Teo PM; Kam MK; Leung SF; Cheung KY; Chan AT
    Med Dosim; 2007; 32(4):263-70. PubMed ID: 17980826
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A deep learning-based method for the prediction of temporal lobe injury in patients with nasopharyngeal carcinoma.
    Ren W; Liang B; Sun C; Wu R; Men K; Chen H; Feng X; Hou L; Han F; Yi J; Dai J
    Phys Med; 2024 May; 121():103362. PubMed ID: 38653120
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Temporal lobe injury after re-irradiation of locally recurrent nasopharyngeal carcinoma using intensity modulated radiotherapy: clinical characteristics and prognostic factors.
    Liu S; Lu T; Zhao C; Shen J; Tian Y; Guan Y; Zeng L; Xiao W; Huang S; Han F
    J Neurooncol; 2014 Sep; 119(2):421-8. PubMed ID: 24986091
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recommendation for a contouring method and atlas of organs at risk in nasopharyngeal carcinoma patients receiving intensity-modulated radiotherapy.
    Sun Y; Yu XL; Luo W; Lee AW; Wee JT; Lee N; Zhou GQ; Tang LL; Tao CJ; Guo R; Mao YP; Zhang R; Guo Y; Ma J
    Radiother Oncol; 2014 Mar; 110(3):390-7. PubMed ID: 24721546
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Late toxicities after intensity-modulated radiotherapy for nasopharyngeal carcinoma: patient and treatment-related risk factors.
    Zeng L; Tian YM; Sun XM; Chen CY; Han F; Xiao WW; Deng XW; Lu TX
    Br J Cancer; 2014 Jan; 110(1):49-54. PubMed ID: 24253503
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.